Results 221 to 230 of about 177,264 (261)

Alpha‐1 adrenergic antagonists, 5‐alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta‐analysis of urodynamic studies

Neurourology and Urodynamics, 2018
F. Fusco, M. Creta, C. de Nunzio, M. Gacci, Vincenzo Li Marzi, Enrico Finazzi Agró   +5 more
semanticscholar   +1 more source

Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

European Urology, 2016
M. Gacci, K. Andersson, C. Chapple, M. Maggi, V. Mirone, M. Oelke, H. Porst, C. Roehrborn, C. Stief, F. Giuliano   +9 more
semanticscholar   +1 more source

Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence

Expert Opinion on Drug Safety, 2018
B. Nardone, K. Orrell, P. Vakharia, D. West   +3 more
semanticscholar   +1 more source

A review of synthetic phosphodiesterase type 5 inhibitors (PDE‐5i) found as adulterants in dietary supplements

Journal of Pharmaceutical and Biomedical Analysis, 2018
C. Kee, Xiaowei Ge, V. Gilard, M. Malet‐Martino, M. Low   +4 more
semanticscholar   +1 more source

Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation.

Clinical Therapeutics, 2017
F. Scaglione, S. Donde, T. Hassan, E. Jannini   +3 more
semanticscholar   +1 more source

Type VII secretion systems: structure, functions and transport models

Nature Reviews Microbiology, 2021
Angel Rivera-Calzada, Nikolaos Famelis, Oscar Llorca   +2 more
exaly  

A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction

European Journal of Health Economics, 2019
Svenn A Hansen, E. Aas, Oddvar Solli
semanticscholar   +1 more source

Targeting inflammation in the treatment of type 2 diabetes: time to start

Nature Reviews Drug Discovery, 2014
Marc Y Donath
exaly  

Phosphodiesterase Type 5 Inhibitors

2009
openaire   +1 more source

Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes

Nature Reviews Drug Discovery, 2011
Frank D Waldron-Lynch, Kevan C Herold
exaly